Phase IIb Study of Umeclidinium (UMEC) Bromide Versus Placebo in Subjects With Asthma
Clinical trial NCT03012061 · COMPLETED
Trial details
- NCT number
- NCT03012061
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-25
- Primary completion
- 2018-05-30
- Enrollment
- 425
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.